Gian Life Care Ltd (BSE: 542918) is a Kanpur, Uttar Pradesh-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹5 Cr, it ranks #5,380 by market cap among the 6,137 Indian listed companies on FinBizNet, and #18 of 18 in Medical Diagnostic Centres. At ₹4.20 (as of 25 Oct 2026), the share price is 68.3% below its 52-week high of ₹13.27 and 3.7% above its 52-week low of ₹4.05. The share price is down 68.3% over one year and down 8.7% over three months.
| Current Price | ₹4.20 |
|---|---|
| Market Cap | ₹5 Cr |
| BSE Code | 542918 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | -108.7 |
| Return on Equity | -0.19% |
| Return on Assets | 0.52% |
| 52-Week Range | ₹4.05 – ₹13.27 |
| 1-Year Price Change | -68.3% |
| 3-Month Price Change | -8.7% |
| Beta (1Y) | 0.2 |
| Headquarters | Kanpur, Uttar Pradesh |
| Website | gianlifecare.org |
| Revenue | ₹1 Cr |
|---|---|
| Net Profit | ₹0 Cr |
| Net Margin | 10.7% |
| EPS (Basic) | ₹0.12 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Gian Life Care Limited provides diagnostic and related healthcare tests and services primarily in India. It offers patient diagnosis, as well as prevention and wellness diagnosis services. The company also provides various types of tests, such as biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, etc. It serves patients, healthcare providers, hospitals, and corporate customers. The company was incorporated in 2018 and is based in Kanpur, India.
1. Medical Labs & Research-This segment provides diagnostic and related healthcare tests and services.
1. Laboratories Pathological Investigations-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | ₹14,231 Cr | 81.5 | 19.70% | ₹231 Cr | +40.7% |
| Metropolis Healthcare Limited | ₹11,002 Cr | 56.7 | 13.37% | ₹450 Cr | +7.3% |
| Throcare Technologies Ltd | ₹7,737 Cr | 46.3 | 28.74% | ₹240 Cr | +8.9% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,465 Cr | 34.5 | 25.22% | — | +20.0% |
| Krsnaa Diagnostics Ltd | ₹1,730 Cr | 16.6 | 10.89% | ₹236 Cr | -38.8% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,597 Cr | 48.2 | 13.84% | ₹88 Cr | -0.3% |
| Gaudium IVF and Women Health Limited | ₹738 Cr | 25 | 16.08% | ₹19 Cr | — |
| Chandan Healthcare Limited | ₹583 Cr | 21.5 | — | ₹81 Cr | — |
| Gian Life Care Ltd | ₹5 Cr | -108.7 | -0.19% | ₹1 Cr | -68.3% |
Listed by market capitalisation. Ratios are shown for context only.
Gian Life Care Ltd is trading at ₹4.20, with a market capitalisation of ₹5 Cr.
Gian Life Care Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Gian Life Care Ltd has a P/E of -108.7 and a return on equity of -0.19%.
Gian Life Care Ltd is listed on the BSE under the scrip code 542918.
Gian Life Care Ltd's share price is down 68.3% over one year and down 8.7% over three months. Its 52-week range is ₹4.05 to ₹13.27.
In Q3 FY26, Gian Life Care Ltd reported revenue of ₹1 Cr and net profit of ₹0 Cr, with basic EPS of ₹0.12 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.